Skip to main content
West Pharmaceutical Services8-K: Board change

Robert F. Friel to become Chair of the Board at West Pharmaceutical Services, effective August 31, 2026.

What happened

Concurrent with the CEO transition, the Lead Independent Director is being elevated to Board Chair. This change in governance leadership can influence long-term corporate strategy, investment priorities, and oversight, signaling a new direction from the top.

Source

SEC EDGARJun 1, 2026

Current report (Form 8-K)

West Pharmaceutical Services 8-K

Filing excerpt

As of the Start Date, Lead Independent Director Robert F. Friel will become Chair of the Board.

sec.gov/Archives/edgar/data/105770/000010577026000080/wst-20260531.htmRead the full source

Other signals in this filing (3)

Extracted by Autobound

From the Signal API record
Signal
8-K: Board change

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
05/31
Filed
Jun 1, 2026

The full record

From the Signal API record

Details

CIK
105770
Accession number
0000105770-26-000080
Timeframe
Next quarter
Filing year
2026
Why it matters
Strategic direction shift
Signal category
Leadership

Extraction

Confidence
High
Relevance
80%
Sentiment
Neutral
Detected
Jun 2, 2026
signal_type
sec-8k
signal_subtype
boardChange

Use this data

Get every 8-K signal for West Pharmaceutical Services and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at West Pharmaceutical Services this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/852c71db-850a-4dce-9451-c269f87a5749 returns this record as JSON. POST /v1/companies/enrich returns every signal for westpharma.com.

{
  "signal_id": "852c71db-850a-4dce-9451-c269f87a5749",
  "signal_type": "sec-8k",
  "signal_subtype": "boardChange",
  "detected_at": "2026-06-02T08:18:23.126+00:00",
  "company": {
    "name": "West Pharmaceutical Services",
    "domain": "westpharma.com"
  },
  "data": {
    "detail": "Concurrent with the CEO transition, the Lead Independent Director is being elevated to Board Chair. This change in governance leadership can influence long-term corporate strategy, investment priorities, and oversight, signaling a new direction from the top.",
    "metrics": {
      "timeframe": "next_quarter"
    },
    "summary": "Robert F. Friel to become Chair of the Board at West Pharmaceutical Services, effective August 31, 2026.",
    "excerpts": "As of the Start Date, Lead Independent Director Robert F. Friel will become Chair of the Board.",
    "relevance": 0.8,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/105770/000010577026000080/wst-20260531.htm",
    "filing_date": "2026-06-01",
    "filing_year": 2026,
    "fiscal_year_end": "05/31",
    "sales_relevance": "Strategic direction shift",
    "signal_category": "leadership"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.